BB Biotech AG (BION) CHF1
Sell:36.85 CHFBuy:37.55 CHF
0.10 CHF
(0.27%)
- This stock can be held in a
Stocks and Shares ISA0.10 CHF
(0.27%)0.10 CHF
(0.27%)Company Information
About this company
BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
Key people
Key facts
- EPIC-
- LocationSwitzerland
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINCH0038389992
- Market capCHF 2.05bn
- Employees86
- Shares in issue55.40m
- ExchangeSIX Swiss Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.